uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Molecular Medicine.
Show others and affiliations
2007 (English)In: Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, E-ISSN 1091-6490, Vol. 104, no 16, 6758-6763 p.Article in journal (Refereed) Published
Abstract [en]

Systematic genome-wide studies to map genomic regions associated with human diseases are becoming more practical. Increasingly, efforts will be focused on the identification of the specific functional variants responsible for the disease. The challenges of identifying causal variants include the need for complete ascertainment of genetic variants and the need to consider the possibility of multiple causal alleles. We recently reported that risk of systemic lupus erythematosus (SLE) is strongly associated with a common SNP in IFN regulatory factor 5 (IRF5), and that this variant altered spicing in a way that might provide a functional explanation for the reproducible association to SLE risk. Here, by resequencing and genotyping in patients with SLE, we find evidence for three functional alleles of IRF5: the previously described exon 1B splice site variant, a 30-bp in-frame insertion/deletion variant of exon 6 that alters a proline-, glutamic acid-, serine- and threonine-rich domain region, and a variant in a conserved polyA+ signal sequence that alters the length of the 3' UTR and stability of IRF5 mRNAs. Haplotypes of these three variants define at least three distinct levels of risk to SLE. Understanding how combinations of variants influence IRF5 function may offer etiological and therapeutic insights in SLE; more generally, IRF5 and SLE illustrates how multiple common variants of the same gene can together influence risk of common disease.

Place, publisher, year, edition, pages
2007. Vol. 104, no 16, 6758-6763 p.
Keyword [en]
interferon pathway, systemic lupus erythematosus
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-11871DOI: 10.1073/pnas.0701266104ISI: 000245869200049PubMedID: 17412832OAI: oai:DiVA.org:uu-11871DiVA: diva2:39640
Available from: 2007-11-01 Created: 2007-11-01 Last updated: 2012-04-13Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Syvänen, Ann-Christine
By organisation
Molecular MedicineDepartment of Medical Sciences
In the same journal
Proceedings of the National Academy of Sciences of the United States of America
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 160 hits
ReferencesLink to record
Permanent link

Direct link